Xiuqi Wei

645 total citations
13 papers, 431 citations indexed

About

Xiuqi Wei is a scholar working on Oncology, Infectious Diseases and Surgery. According to data from OpenAlex, Xiuqi Wei has authored 13 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Xiuqi Wei's work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Xiuqi Wei is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Xiuqi Wei collaborates with scholars based in China and United States. Xiuqi Wei's co-authors include Wenbin Tan, Jingyu Su, Xiaoling Cao, Huimin Wan, Hui Wang, Wenjuan Zeng, Kunyu Yang, Hui Wang, Hui Wang and Li Du and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, Frontiers in Oncology and Journal of Medical Virology.

In The Last Decade

Xiuqi Wei

13 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuqi Wei China 8 259 123 110 90 75 13 431
Jingyu Su China 5 229 0.9× 100 0.8× 91 0.8× 71 0.8× 63 0.8× 10 359
Xiaobei Chen China 9 239 0.9× 55 0.4× 114 1.0× 79 0.9× 168 2.2× 20 531
Jianlei Lv China 8 346 1.3× 108 0.9× 57 0.5× 165 1.8× 58 0.8× 10 496
Guorong Gu China 7 179 0.7× 46 0.4× 78 0.7× 95 1.1× 52 0.7× 15 357
Stéphane Jouveshomme France 8 425 1.6× 79 0.6× 124 1.1× 214 2.4× 92 1.2× 22 642
Tangxi Guo China 6 234 0.9× 65 0.5× 55 0.5× 123 1.4× 96 1.3× 6 354
Xingzhong Hu China 8 388 1.5× 133 1.1× 73 0.7× 134 1.5× 112 1.5× 15 522
Chaoyue Chen China 7 285 1.1× 80 0.7× 75 0.7× 116 1.3× 134 1.8× 17 452
Jiarui Feng China 8 244 0.9× 39 0.3× 149 1.4× 118 1.3× 124 1.7× 11 497
Zheyi Han United States 8 309 1.2× 49 0.4× 317 2.9× 151 1.7× 73 1.0× 14 749

Countries citing papers authored by Xiuqi Wei

Since Specialization
Citations

This map shows the geographic impact of Xiuqi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuqi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuqi Wei more than expected).

Fields of papers citing papers by Xiuqi Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuqi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuqi Wei. The network helps show where Xiuqi Wei may publish in the future.

Co-authorship network of co-authors of Xiuqi Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuqi Wei. A scholar is included among the top collaborators of Xiuqi Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuqi Wei. Xiuqi Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhang, Nan, et al.. (2024). Diagnostic algorithm based on ratio of ascites-serum tumor markers is superior to tumor markers in the differentiation of benign ascites from malignant ascites. The American Journal of the Medical Sciences. 368(4). 361–368. 1 indexed citations
3.
Wei, Xiuqi, et al.. (2022). Down-regulated lncRNA ROR in tumor-educated platelets as a liquid-biopsy biomarker for nasopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology. 149(8). 4403–4409. 11 indexed citations
4.
Wang, Dongyuan, Xiuqi Wei, Chang Liu, et al.. (2022). MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysis. BMC Gastroenterology. 22(1). 29–29. 7 indexed citations
5.
Sun, Kaiyu, Hui Wang, Xianqun Xu, et al.. (2021). Tumor-Educated Platelet miR-18a-3p as a Novel Liquid-Biopsy Biomarker for Early Diagnosis and Chemotherapy Efficacy Monitoring in Nasopharyngeal Carcinoma. Frontiers in Oncology. 11. 736412–736412. 6 indexed citations
6.
Li, Guiling, Li Du, Xiaoling Cao, et al.. (2021). Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients. BMC Infectious Diseases. 21(1). 299–299. 27 indexed citations
7.
Wei, Xiuqi, Wenjuan Zeng, Jingyu Su, et al.. (2020). Hypolipidemia is associated with the severity of COVID-19. Journal of clinical lipidology. 14(3). 297–304. 241 indexed citations
8.
Wei, Xiuqi, Jingyu Su, Kunyu Yang, et al.. (2020). Elevations of serum cancer biomarkers correlate with severity of COVID‐19. Journal of Medical Virology. 92(10). 2036–2041. 55 indexed citations
9.
Du, Li, Xiaoling Cao, Jing Chen, et al.. (2020). Fecal occult blood and urinary cytology tests for rapid screening of inflammatory infection in the gastrointestinal and urological systems in patients with Coronavirus disease 2019. Journal of Clinical Laboratory Analysis. 35(1). e23626–e23626. 4 indexed citations
10.
Wei, Xiuqi, Jingyu Su, Huimin Wan, et al.. (2020). SARS-COV-2 Infection Causes Dyslipidemia and Increases Levels of Cancer Biomarkers in COVID-19 Patients. SSRN Electronic Journal. 3 indexed citations
11.
Wang, Hui, Xiuqi Wei, Bian Wu, et al.. (2019). <p>Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis</p>. Cancer Management and Research. Volume 11. 3351–3360. 35 indexed citations
12.
Luo, Changliang, Yuan Rong, Hao Chen, et al.. (2019). A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 18. 1078114280–1078114280. 19 indexed citations
13.
Du, Li, Zhiwen Lu, Ting Xu, et al.. (2018). Ascitic cholesterol is superior to serum‐ascites albumin gradient in the detection of non‐portal hypertensive ascites and the diagnosis of mixed ascites. Alimentary Pharmacology & Therapeutics. 49(1). 91–98. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026